The 992-series 911 Turbo prepares for a mid-cycle refresh that includes a hybrid twist. In Turbo S flavor, maximum output could be around 700 metric horsepower ...

Porsche's Cayenne is the larger of the two Porsche SUVs and is also more expensive than the Macan across all of the available ...

A hybrid Cayenne takes on the meanest M4 around, and it’s so close it takes a slow-motion action replay to say who’s first in ...

The 631bhp Porsche Cayenne Turbo GT has set a new precedent on the road for high-riding high performance SUVs, so Steve Sutcliffe hit the track to find out how that translates on track, and to see how ...

Porsche Cayenne Turbo GT Package is no ordinary SUV. Watch it roar past 300 KM/H on the German Autobahn, and feel its track-tested dynamics and brutal V8 power in full POV. 🏁 Blending performance, ...

You can buy this coupe in 1.80 - 2.47 Cr (ex-showroom). Q ) Which are the most popular Porsche cars in India? A ) The most popular Porsche cars in India include the 911, Cayenne, Macan.

The new BMW X5 and Porsche Cayenne are both totally new ... Under the hood of this Cayenne S is the 2.9-liter twin turbo V6 that makes 434 horsepower and 405 lb-ft of torque.

*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title ...

The registration deadline for Round 2 of the Prime Minister Internship Scheme 2025 has been extended to April 15, giving students and young professionals more time to apply. The scheme offers year ...

Porsche Cars North America (PCNA) has announced that Porsche Experience Center Los Angeles (PECLA) is expanding its track experiences with the introduction of two new demonstration lap options.

Which means that they, and Porsche’s GT division itself, would never have come to be had it not been for the Carrera RS 2.7, like the one for sale here. The RS 2.7 is a car of many firsts.

Racing toward a $1.6 billion market, the biotech stopped work on RLYB212 in a rare maternal immune disorder in response to phase 2 data. RLYB212, an anti-HPA-1a antibody, was in phase 2 ...